| Laser Seeker |
CONTACT LENSES
According to the consumer group Which? some daily
contact lenses are virtually identical to the
more expensive weekly or monthly products. Users
could be wasting up to £190 a year on
longer-life lenses, when some daily lenses were
made of similar material as monthly pairs.
A contact lens maker and an optician working for
Which? found that daily lenses from Coopervision,
Sauflon, Johnson & Johnson and Bausch &
Lomb, were virtually the same as longer-life
products, with slight differences in diameter,
thickness and curves, which they said would not
affect re-use. Only Ciba Vision's lenses were
totally different.
The British Contact Lens Association said,
There is a significant risk to patients who
re-use daily disposable lenses without the proper
care procedures. Eye expert Prof Roger
Buckley warned, "If contact lenses are not
worn according to professional advice, they are
capable of harm, even blinding." (Source: Times Online, Apr/06) |
|
|
LASER EYE SURGERY
High
street chain Boots contacted patients who had laser eye
surgery at a clinic amid fears the equipment used could
be faulty. Boots said it is looking into the claims
"as a matter of urgency" but believes its
equipment is safe. The move follows reports of legal
action in the US. A lawsuit filed there claims some of
the Autonomous Ladarvision Systems, which are used in
Boots' nine eye treatment clinics across Britain, can
develop faults leading to blurred vision.
The laser machine used in Boots' London eye surgery
clinic in Regent Street was said to be from a batch
identified in 2001 by Swiss-owned health care company
Alcon as potentially having a problem. The machine was
modified by the laser manufacturer after concerns were
raised, a Boots spokeswoman said.
A statement from Alcon claimed the allegations made in
the US lawsuit were "completely unsupported by
scientific or legitimate evidence". The statement
added: "The Ladarvision is safe and effective. It
has been extensively tested in clinical trials and was
approved for its intended use by the US Food and Drug
Administration and other regulatory bodies around the
world."
Around 49 patients who were treated with the London laser
before it was modified are being contacted by the company
to discover if they have suffered any adverse effects. A
Boots spokeswoman said, "There have been allegations
that much older lasers may have been reported as having
problems. We are looking for evidence of that from Alcon.
However, we have no reason to suspect any problems with
our lasers in the UK. There is no reason to worry."
The company is being sued in North Carolina District
Court by EBW Laser, which acquired 10 of its lasers to
lease to US clinics, and alleges that two of the machines
were "badly malfunctioning". In its statement
Alcon said it looked into the machines' success rate
voluntarily to prevent potential misfunctions. Laser
surgery costs £1,250 an eye at Boots' clinics, and is
performed on around 100,000 people each year in Britain.
Negligence
claims involving laser eye surgery against doctors
belonging to the Medical Defence Union (MDU) have more
than doubled in the last six years. The MDU, which is the
largest insurer for UK doctors, said that while some of
the claims were over faulty surgery many more centred on
patients' "unrealistic expectations" about what
could be achieved. The figures, released by the union,
show that claims over laser eye surgery have increased by
166% in six years, and now account for a third of all
ophthalmology claims.
The MDU has increased its subscription rates for laser
eye surgeons and advised them how to minimise the risk of
a claim. About 100,000 people who are tired of wearing
glasses or contact lenses undergo corrective laser eye
surgery in the UK every year. The procedure, which was
introduced in the early 90s, can cost thousands of
pounds. Consumer experts warned that patients undergoing
laser eye surgery were not being told about the risks
they could be taking with their sight.
The investigation by Health Which? also revealed any
doctor could carry out the treatment after just a few
days of training, no specialist qualifications were
needed. The magazine also found complication rates varied
between surgeons and clinics. Earlier, the medical
journal Ophthalmology said the failure rate for eye
surgery was one in 10, not the one in 1,000 figure widely
advertised. Rebecca Petris is one patient who found
surgery did not fix her vision.
She said, "I can no longer drive. I've difficulty
reading at most distances. I've severe double vision. My
night vision is just about gone. It's very difficult to
see in dim light or dark circumstances." Dr
Christine Tomkins, of the MDU, said, "Patients need
to understand what the risks are. And they need to think
about whether or not the benefits they think they will
get from the procedure actually outweigh the risks, in
order to decide whether they want to go ahead with
it."
In very rare cases, complications can lead to corneal
ectasia, where fluid pressure builds up on the eye.
Patients can need a corneal transplant to correct the
condition. Other complications, though deemed
"minor" by clinics, occur "relatively
frequently", according to a recent review by the
American Academy of Ophthalmology. Patients can
experience dry eyes or night vision problems, which can
affect ability to drive or work in the evening or in dim
light.
Eye surgeon David Gartry said the risks need to be put
into perspective. "You can see that something
serious happening would be very rare indeed," he
said. "But if the surgeon tells the patients they
will have perfect vision afterwards and they will throw
away their glasses, that raises unduly high
expectations." The MDU is advising surgeons that
patients must have enough time to ask questions and
absorb information before making a decision to go ahead
with the procedure.
|
|
|